A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply.

View/ Open
Access
info:eu-repo/semantics/embargoedAccessDate
2023Author
Zhang, KaiTeoh, Jeremy
del Pilar Laguna Pes, Maria
Ng, Chi-Fai
de la Rosette, Jean J. M. C. H.
Metadata
Show full item recordCitation
Zhang, K., Teoh, J., del Pilar Laguna Pes, M., Ng, C. ve de la Rosette, J. J. M. C. H. (2023). A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply. Journal of Urology, 209(5), 847-848. https://dx.doi.org/10.1097/JU.0000000000003405Abstract
To the Editor: We appreciate this opportunity toaddress the concerns in the comment by Jin et al on ourarticle,1evaluating the adverse events and quality of lifeafter irreversible electroporation (IRE) for the ablationof localized low-intermediate risk prostate cancer.